Dr. Pradip Maiti is Co-Founder and serves as Chief Scientific Officer. He has more than 35 years Experience in the Biopharmaceutical Industry with a focus on Developing and Commercializing Antibody Immunotherapeutics.
Dr. Maiti has been an integral part of our many corporate achievements including R & D, Manufacturing, Regulatory Affairs, Clinical Development and Developing our Intellectual Property Portfolio.
Prior to 2004, Dr. Maiti was with Novopharm Biotech Inc / Viventia Biotech Inc as Senior Scientist & Manager. He served in a variety of Technical and Leadership roles in R&D, Manufacturing, Regulatory Affairs & Clinical Development. His technical focus was Human Monoclonal Antibody Cancer Immunotherapeutics with approved INDs from the FDA and Health Canada..
He is an Inventor and researcher with more than 20 patents and more than 30 publications.
Dr. Maiti has a MSc. in Microbiology from Kalyani University and PhD. in Microbiology-Immunology from All India Institute of Medical Sciences, New Delhi.